-
Mashup Score: 14Companies That Replace People with AI Will Get Left Behind - 10 month(s) ago
Companies are integrating AI into their operations so quickly that job losses are likely to mount before the gains arrive. White-collar workers might be especially vulnerable in the short-term.The speed of this adoption presents an opportunity for companies to step up their pace of innovation, however — and if enough companies to go on offensive, then we won’t have to worry about AI unemployment….
Source: Harvard Business ReviewCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
This is a healthcare blog for those interested in acute care pediatrics with perspectives and information on acute illness and injury in children.
Source: davidepsteinmd.blogspot.comCategories: Latest Headlines, PediatricsTweet-
How can we foster a culture within the healthcare industry that values the human element, recognizing the importance of both financial stability and the satisfaction and fulfillment of medical professionals? #business #people #medicine #culture https://t.co/umMTNXUDM4 https://t.co/Cs0xIsD1yH
-
-
Mashup Score: 3
Separated by Four Decades, Two Business Giants — David Finn and Hubert Joly — Unite on the Endless Journey to Transform the Modern…
Source: MediumCategories: Healthcare Professionals, Latest HeadlinesTweet-
Separated by Four Decades, Two Business Giants — David Finn and @HubertJoly_ — Unite on the Endless Journey to Transform the Modern Business Model to Center Around #People and #Purpose. My words on @PurposeonMedium. #purposedrivenbusiness #socialimpact https://t.co/4jeSqW4fzr
-
-
Mashup Score: 0Political parties: Gatekeepers of democracy - 12 month(s) ago
As I was reading the seminal book How Democracies Die by Steven Levitsky and Daniel Ziblatt, one of its quotes deeply resonated with me: “Democracies may die at the hands not of generals but of elected leaders—presidents or prime ministers who subvert the very process that brought them to power. Some of these leaders dismantle democracy quickly, as Hitler did in the wake of the 1933 Reichstag…
Source: Deccan HeraldCategories: Latest Headlines, Oncologists2Tweet-
My thought piece in Deccan Herald. https://t.co/ShJsjpS9io #Democracy #India #People
-
-
Mashup Score: 0Physicians as Hospital Influencers: A New Era - 1 year(s) ago
This is a healthcare blog for those interested in acute care pediatrics with perspectives and information on acute illness and injury in children.
Source: davidepsteinmd.blogspot.comCategories: Latest Headlines, PediatricsTweet-
People are the key to establishing the reputation that a hospital craves. #hospitalreputation #communitytrust #people #socialmedia #physicians #physician #doctor #doctors Article Link: https://t.co/owxliULg5s
-
-
Mashup Score: 4
Empagliflozin provided clinically relevant placebo-corrected reductions in HbA1c, whereas linagliptin did not, and might offer a new treatment option for young people with type 2 diabetes.
Categories: Endocrinology, Latest HeadlinesTweet-
Efficacy and safety of the #SGLT2 inhibitor #empagliflozin vs placebo and the #DPP-4 inhibitor #linagliptin versus placebo in #young #people with type 2 #diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial https://t.co/fdz3fO1cyU #T2D #youth
-
-
Mashup Score: 1Challenges in the treatment of young people with type 2 diabetes - 1 year(s) ago
The increasing prevalence of obesity in children and adolescents has been followed by an increased rate of type 2 diabetes.1 In children and adolescents, type 2 diabetes takes a more aggressive course than in adults with a more rapid decline in β-cell function, high treatment failure, and accelerated development of diabetes-related complications.2 Pharmacological treatments approved by the…
Categories: Endocrinology, Latest HeadlinesTweet-
Sten Madsbad comments on: Challenges in the treatment of #young #people with type 2 #diabetes https://t.co/VshrCtZo8q #T2D #youth
-
-
Mashup Score: 0
Empagliflozin provided clinically relevant placebo-corrected reductions in HbA1c, whereas linagliptin did not, and might offer a new treatment option for young people with type 2 diabetes.
Categories: Endocrinology, Latest HeadlinesTweet-
Efficacy and safety of the #SGLT2 inhibitor #empagliflozin vs placebo & the #DPP-4 inhibitor #linagliptin versus placebo in #young #people with type 2 #diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial https://t.co/fdz3fO1cyU #T2D #youth
-
-
Mashup Score: 0Challenges in the treatment of young people with type 2 diabetes - 1 year(s) ago
The increasing prevalence of obesity in children and adolescents has been followed by an increased rate of type 2 diabetes.1 In children and adolescents, type 2 diabetes takes a more aggressive course than in adults with a more rapid decline in β-cell function, high treatment failure, and accelerated development of diabetes-related complications.2 Pharmacological treatments approved by the…
Categories: Endocrinology, Latest HeadlinesTweet-
Sten Madsbad comments on: Challenges in the treatment of #young #people with type 2 #diabetes https://t.co/VshrCtZo8q #T2D #youth
-
-
Mashup Score: 0Challenges in the treatment of young people with type 2 diabetes - 1 year(s) ago
The increasing prevalence of obesity in children and adolescents has been followed by an increased rate of type 2 diabetes.1 In children and adolescents, type 2 diabetes takes a more aggressive course than in adults with a more rapid decline in β-cell function, high treatment failure, and accelerated development of diabetes-related complications.2 Pharmacological treatments approved by the…
Categories: Endocrinology, Latest HeadlinesTweet-
Also read the Linked Comment by Sten Madsbad: Challenges in the treatment of #young #people with type 2 #diabetes https://t.co/VshrCtZo8q #T2D
-
RT @SpirosMargaris: Companies That Replace #People with #AI Will Get Left Behind https://t.co/09fGxG8KU9 #fintech #futureofwork #Artifici…